Cargando…
The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
Autor principal: | Talbert, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437693/ https://www.ncbi.nlm.nih.gov/pubmed/18693784 http://dx.doi.org/10.18553/jmcp.2008.14.S8-A.16 |
Ejemplares similares
-
Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008) -
Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013) -
Evolving Issues in the Clinical and Managed Care Settings on the Management of Menopause Following the Women's Health Initiative
por: Lukes, Andrea
Publicado: (2008) -
Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting
por: Mullins, C. Daniel
Publicado: (2012) -
AHRQ's Effective Health Care Program: Its Impact on Managed Care
por: Fleming, William K.
Publicado: (2007)